AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20724348 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12
Study 18448227 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental handpiece
Number of subjects: 141
Study 18448227 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonicare electric toothbrush
Number of subjects: 141
Study 18448227 — intervention group
Group type: COMPARATOR
Intervention: Oral B 30 toothbrush
Number of subjects: 141
Study 18448227 — intervention group
Group type: COMPARATOR
Intervention: Braun electric toothbrush
Number of subjects: 141
Study 16000994 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-sample GFR measurements using Tc-DTPA
Number of subjects: 325
Study 16000994 — intervention group
Group type: EXPERIMENTAL
Intervention: One-sample GFR estimates using a new general equation
Number of subjects: 325
Study 14523532 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetazoline without preservative (Nasivin sanft 0.05% spray)
Number of subjects: 307
Study 14523532 — intervention group
Group type: COMPARATOR
Intervention: Oxymetazoline with preservative
Number of subjects: 307
Study 14523532 — intervention group
Group type: COMPARATOR
Intervention: Xylometazoline with preservative
Number of subjects: 307
Study 11789002 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 0
Study 11789002 — intervention group
Group type: COMPARATOR
Intervention: Control group without statins
Number of subjects: 0
Study 11789002 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment in patients with baseline dyslipidaemia
Number of subjects: 0
Study 9364291 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg, orally once daily for 3 days)
Number of subjects: 481
Study 9364291 — intervention group
Group type: COMPARATOR
Intervention: Co-amoxiclav (10 mg/kg in a 4:1 ratio, orally three times daily for 5-10 days)
Number of subjects: 481
Study 9364291 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 481
Study 9364291 — intervention group
Group type: COMPARATOR
Intervention: Co-amoxiclav
Number of subjects: 481
Study 1539845 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 0.075 mg/kg
Number of subjects: 110
Study 1539845 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.25 mg/kg
Number of subjects: 110
Study 1539845 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.15 mg/kg
Number of subjects: 110
Study 1539845 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 110
Study 1539845 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 110
Study 1539845 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol
Number of subjects: 110
Study 3577453 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitaferro, Folicombin and additional vitamins
Number of subjects: 39
Study 31652180 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted debriefing with trainees' errors (TE)
Number of subjects: 322
Study 31652180 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted debriefing with simulated errors (SE)
Number of subjects: 322
Study 31652180 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 322
Study 29122125 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopically‐assisted reduction and internal fixation (ARIF)
Number of subjects: 75
Study 29122125 — intervention group
Group type: COMPARATOR
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 75
Study 25800242 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenoma risk model developed from baseline data and logistic regression analysis.
Number of subjects: 1875
Study 25800242 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline questionnaires on clinical risk factors and family history.
Number of subjects: 1875
Study 23870606 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone/formoterol (100/10 µg BID)
Number of subjects: 0
Study 23870606 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone (100 µg BID)
Number of subjects: 0
Study 23870606 — intervention group
Group type: COMPARATOR
Intervention: Formoterol (10 µg BID)
Number of subjects: 0
Study 21655065 — intervention group
Group type: COMPARATOR
Intervention: OAC (omeprazole, amoxicillin, clarithromycin)
Number of subjects: 300
Study 21655065 — intervention group
Group type: EXPERIMENTAL
Intervention: OAL (omeprazole, amoxicillin, levofloxacin)
Number of subjects: 300
Study 21655065 — intervention group
Group type: EXPERIMENTAL
Intervention: OAL-R (omeprazole, amoxicillin, levofloxacin, rifaximin)
Number of subjects: 300
Study 19508314 — intervention group
Group type: EXPERIMENTAL
Intervention: Gynecologic evaluation
Number of subjects: 949
Study 19508314 — intervention group
Group type: COMPARATOR
Intervention: No gynecologic evaluation
Number of subjects: 949
Study 16923483 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 hours of unsupervised training on the GI Mentor
Number of subjects: 45
Study 16923483 — intervention group
Group type: COMPARATOR
Intervention: No simulator experience
Number of subjects: 45
Study 15225153 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard antidepressant medication
Number of subjects: 12
Study 15225153 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous mania
Number of subjects: 12
Study 11902552 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical management (lymph-node surgery)
Number of subjects: 0
Study 11902552 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective lymph-node dissection
Number of subjects: 0
Study 11902552 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph-node biopsy
Number of subjects: 0
Study 11902552 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant nodal radiotherapy
Number of subjects: 0
Study 11902552 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy after lymph-node dissection
Number of subjects: 0
Study 11902552 — intervention group
Group type: COMPARATOR
Intervention: Systemic chemotherapy
Number of subjects: 0
Study 9491554 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid chromatography-tandem mass spectrometry (LC-MS-MS)
Number of subjects: 0
Study 7511751 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 20
Study 7511751 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 3222045 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser iridotomy
Number of subjects: 20
Study 3222045 — intervention group
Group type: COMPARATOR
Intervention: Pilocarpine (nonlaser-treated group)
Number of subjects: 20
Study 1955900 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin 'A'
Number of subjects: 20
Study 1955900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 1955900 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated toxin injections
Number of subjects: 20
Study 1080438 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary bypass surgery
Number of subjects: 100
Study 1080438 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 100
Study 27854117 — intervention group
Group type: EXPERIMENTAL
Intervention: PAV plus SIMV
Number of subjects: 46
Study 27854117 — intervention group
Group type: COMPARATOR
Intervention: SIMV
Number of subjects: 46
Study 30121728 — intervention group
Group type: EXPERIMENTAL
Intervention: Taking It to the Pews (TIPS) intervention
Number of subjects: 4
Study 30121728 — intervention group
Group type: COMPARATOR
Intervention: Standard-information control arm
Number of subjects: 4
Study 28646377 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-month diabetes education program for community health workers (patients n=62)
Number of subjects: 118
Study 28646377 — intervention group
Group type: COMPARATOR
Intervention: Education course in other health issues for community health workers (patients n=56)
Number of subjects: 118
Study 25958474 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with a 637 nm GaAlAs laser, 40 mW, continuous wave, 6.26 J/cm2 per implant, applied daily for 7 days post-surgery
Number of subjects: 12
Study 25958474 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 12
Study 25958474 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LLLT and control groups
Number of subjects: 12
Study 23307315 — intervention group
Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate (MPA) 10 mg BD for three cycles
Number of subjects: 66
Study 23307315 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerial parts of wood betony (AWB) 5 g TDS for three months
Number of subjects: 66
Study 22238738 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 ml of 6% triphala mouthwash
Number of subjects: 57
Study 22238738 — intervention group
Group type: COMPARATOR
Intervention: 15 ml of 0.2% chlorhexidine (active control)
Number of subjects: 57
Study 22238738 — intervention group
Group type: COMPARATOR
Intervention: no mouthwash (passive control)
Number of subjects: 57
Study 18991979 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) supplementation (500 mg/day)
Number of subjects: 61
Study 18991979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 16762346 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine artery ligation during cesarean section (group I)
Number of subjects: 48
Study 16762346 — intervention group
Group type: COMPARATOR
Intervention: Cesarean section only (group II)
Number of subjects: 48
Study 15009104 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of calcipotriol ointment once daily and betamethasone dipropionate ointment once daily
Number of subjects: 7
Study 15009104 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol monotherapy
Number of subjects: 7
Study 15009104 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone dipropionate monotherapy
Number of subjects: 7
Study 11283119 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 488
Study 11283119 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 488
Study 11283119 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen and Placebo
Number of subjects: 488
Study 9542675 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral itraconazole 200 mg twice daily for 7 days, followed by placebo for 7 days (n = 153)
Number of subjects: 304
Study 9542675 — intervention group
Group type: COMPARATOR
Intervention: Placebo in the morning and oral terbinafine 250 mg in the evening for 14 days (n = 151)
Number of subjects: 304
Study 8117224 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg oral dose)
Number of subjects: 10
Study 8117224 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3403825 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose dipyridamole-echocardiography test (0.84 mg/kg body weight over 10 min)
Number of subjects: 83
Study 3403825 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-electrocardiography test
Number of subjects: 83
Study 31212071 — intervention group
Group type: EXPERIMENTAL
Intervention: Indwelling Foley balloon catheter
Number of subjects: 70
Study 31212071 — intervention group
Group type: COMPARATOR
Intervention: Control group (without catheter placement)
Number of subjects: 70
Study 29360920 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline + Vitamin K1 cream
Number of subjects: 126
Study 29360920 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline + Vehicle
Number of subjects: 126
Study 27192695 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFA-rich Inuit diet
Number of subjects: 233
Study 25604761 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-lasting insecticidal net screens (LLIS) with targeted treatment (TT) of breeding sites
Number of subjects: 1000
Study 25604761 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 1000
Study 23754384 — intervention group
Group type: EXPERIMENTAL
Intervention: Postextinction administration of L-dopa
Number of subjects: 0
Study 19261278 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin treatment starting from the first day of controlled ovarian hyperstimulation in 1503 cycles
Number of subjects: 3154
Study 19261278 — intervention group
Group type: COMPARATOR
Intervention: No treatment in the remaining 922 cycles
Number of subjects: 3154
Study 19205092 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg and Valsartan 160 mg
Number of subjects: 105
Study 19205092 — intervention group
Group type: COMPARATOR
Intervention: Ramipril 5 mg and Felodipine 5 mg
Number of subjects: 105
Study 17011843 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical prednisolone and diclofenac (verum)
Number of subjects: 32
Study 17011843 — intervention group
Group type: COMPARATOR
Intervention: Lubricating eye drops (placebo)
Number of subjects: 32
Study 14520619 — intervention group
Group type: EXPERIMENTAL
Intervention: Predialysis psychoeducational intervention (PPI)
Number of subjects: 297
Study 14520619 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control group
Number of subjects: 297
Study 11889276 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard behavioral group intervention and standard intervention supplemented with spiritual strategies
Number of subjects: 529
Study 11889276 — intervention group
Group type: COMPARATOR
Intervention: Self-help strategies
Number of subjects: 529
Study 11889276 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention group (top decile for weight loss)
Number of subjects: 529
Study 9596422 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of flumazenil at 0.5 mg/h for 5 hours (CI group)
Number of subjects: 100
Study 9596422 — intervention group
Group type: COMPARATOR
Intervention: Control group (CIN)
Number of subjects: 100
Study 8165850 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi-Liq (25 micrograms)
Number of subjects: 323
Study 8165850 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi-Lyoph (25 micrograms)
Number of subjects: 323
Study 8165850 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster dose of Vi-Liq (27 to 34 months after primary immunization)
Number of subjects: 323
Study 8165850 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 323
Study 3280097 — intervention group
Group type: EXPERIMENTAL
Intervention: Real time ultrasound
Number of subjects: 350
Study 3280097 — intervention group
Group type: COMPARATOR
Intervention: Intravenous urography
Number of subjects: 350
Study 3280097 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal ultrasound
Number of subjects: 350
Study 31254422 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 plus oxaliplatin (SOX)
Number of subjects: 663
Study 31254422 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 plus cisplatin (CS)
Number of subjects: 663
Study 31254422 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 in SOX
Number of subjects: 663
Study 31254422 — intervention group
Group type: COMPARATOR
Intervention: Both SOX and CS
Number of subjects: 663
Study 28031175 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab + FOLFOX
Number of subjects: 2559
Study 28031175 — intervention group
Group type: COMPARATOR
Intervention: FOLFOX
Number of subjects: 2559
Study 26021722 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose capecitabine (1,000 mg/m² twice daily on days 1 to 14 of every 21 days)
Number of subjects: 926
Study 26021722 — intervention group
Group type: COMPARATOR
Intervention: Approved-dose capecitabine (1,250 mg/m² twice daily on days 1 to 14 of every 21 days)
Number of subjects: 926
Study 24136736 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnitude-based multi-echo MRI for estimating hepatic proton density fat fraction (PDFF)
Number of subjects: 29
Study 22759439 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual counseling on diet and physical activity by a public health nurse, and two group counseling sessions until offspring's age of five years.
Number of subjects: 0
Study 22759439 — intervention group
Group type: COMPARATOR
Intervention: Control group recruited among families who visited the same clinics one year earlier.
Number of subjects: 0
Study 19399649 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse postural test (RPT)
Number of subjects: 51
Study 19399649 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls and primary hypertensives (after supine resting)
Number of subjects: 51
Study 19399649 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with APA
Number of subjects: 51
Study 17325585 — intervention group
Group type: EXPERIMENTAL
Intervention: Sm‐EDTMP (37 MBq x kg)
Number of subjects: 100
Study 17325585 — intervention group
Group type: COMPARATOR
Intervention: Sr (150 MBq)
Number of subjects: 100
Study 17325585 — intervention group
Group type: EXPERIMENTAL
Intervention: Both radionuclides
Number of subjects: 100
Study 17325585 — intervention group
Group type: EXPERIMENTAL
Intervention: Sm‐EDTMP and Sr
Number of subjects: 100
Study 15380916 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine enriched total parenteral nutrition
Number of subjects: 23
Study 15380916 — intervention group
Group type: COMPARATOR
Intervention: Isonitrogenous control solution
Number of subjects: 23
Study 11449622 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with ifosfamide 1.6 g/m2 (d 1-3) and carboplatin (AUC 4, d1) every three weeks, with 21 patients receiving amifostine 740 mg/m2 d1-3 followed by standard radiation therapy (50.4 Gy percutaneous and high-dose-rate-after-loading for 21 patients, 2 x 5 Gy).
Number of subjects: 34
Study 11449622 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with ifosfamide and carboplatin.
Number of subjects: 34
Study 9793284 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric toothbrush with orthodontic brush head
Number of subjects: 84
Study 9793284 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 84
Study 7657052 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham feeding (sight and smell of a meal, no taste)
Number of subjects: 11
Study 7657052 — intervention group
Group type: COMPARATOR
Intervention: Intravenous glucose tolerance test (25 g glucose/4 min)
Number of subjects: 11
Study 2708766 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible lens material (Dk 92)
Number of subjects: 11
Study 2708766 — intervention group
Group type: COMPARATOR
Intervention: Rigid lens material (Dk 60)
Number of subjects: 11
Study 2708766 — intervention group
Group type: COMPARATOR
Intervention: Eye patching
Number of subjects: 11
Study 2708766 — intervention group
Group type: EXPERIMENTAL
Intervention: Time (2-hour period)
Number of subjects: 11
Study 765356 — intervention group
Group type: EXPERIMENTAL
Intervention: Marathon group 1
Number of subjects: 0
Study 765356 — intervention group
Group type: EXPERIMENTAL
Intervention: Marathon group 2
Number of subjects: 0
Study 765356 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 0
Study 31291444 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program (Health Magic Box)
Number of subjects: 173
Study 31291444 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 173
Study 28080126 — intervention group
Group type: EXPERIMENTAL
Intervention: College course on terrorism (treatment)
Number of subjects: 0
Study 28080126 — intervention group
Group type: COMPARATOR
Intervention: Wait-listed students (control)
Number of subjects: 0
Study 28080126 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment classes from universities across the United States (Study 2)
Number of subjects: 0
Study 25772955 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator training (Group-A)
Number of subjects: 30
Study 25772955 — intervention group
Group type: COMPARATOR
Intervention: No simulator training (Group-B)
Number of subjects: 30
Study 25772955 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Group-A and Group-B
Number of subjects: 30
Study 22591260 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser gingivectomy (940‐nm diode laser, ezlase, Biolase Technology Inc) as an adjunct to nonsurgical periodontal treatment
Number of subjects: 30
Study 22591260 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical periodontal treatment only
Number of subjects: 30
Study 21367933 — intervention group
Group type: EXPERIMENTAL
Intervention: rosiglitazone (8 mg/d)
Number of subjects: 53
Study 21367933 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 53
Study 20032535 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel antiviral agents
Number of subjects: 0
Study 17233233 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage-targeted physical activity intervention
Number of subjects: 207
Study 17233233 — intervention group
Group type: COMPARATOR
Intervention: Low-sodium diet brochures (Control)
Number of subjects: 207
Study 15035683 — intervention group
Group type: EXPERIMENTAL
Intervention: Soya milk (0.44 mg isoflavones/kg body weight)
Number of subjects: 57
Study 15035683 — intervention group
Group type: EXPERIMENTAL
Intervention: Tempeh (0.44 mg isoflavones/kg body weight)
Number of subjects: 57
Study 15035683 — intervention group
Group type: COMPARATOR
Intervention: Textured vegetable protein (TVP) (0.44 mg isoflavones/kg body weight)
Number of subjects: 57
Study 11506196 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplementation with Lactobacillus rhamnosus HN001
Number of subjects: 27
Study 11506196 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplementation with Bifidobacterium lactis HN019
Number of subjects: 27
Study 11506196 — intervention group
Group type: COMPARATOR
Intervention: Dietary run-in of milk alone
Number of subjects: 27
Study 9551030 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin prescription by specialists
Number of subjects: 138
Study 9551030 — intervention group
Group type: COMPARATOR
Intervention: Warfarin prescription by general practitioners
Number of subjects: 138
Study 9551030 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin prescription for elderly females by specialists
Number of subjects: 138
Study 9551030 — intervention group
Group type: COMPARATOR
Intervention: Warfarin prescription for elderly females by general practitioners
Number of subjects: 138
Study 9551030 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin prescription for elderly males by specialists
Number of subjects: 138
Study 9551030 — intervention group
Group type: COMPARATOR
Intervention: Warfarin prescription for elderly males by general practitioners
Number of subjects: 138